<div id="readability-page-1">Eikon Therapeutics, Inc (NASDAQ:EIKN) IPO will take place February, 05 on the NASDAQ exchange under the ticker EIKN. The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on August 04, 2026. See also: Benzinga IPO Calendar <h3>About Eikon Therapeutics, Inc</h3> Eikon Therapeutics, Inc is a late-stage clinical biopharmaceutical company dedicated to building a global, fully-integrated organization developing important, innovative medicines to address serious unmet medical needs. See also: Benzinga's Most Shorted Stocks This article was generated by Benzinga's automated content engine and reviewed by an editor.</div>

SBIO

ANIK

NBSE.ESC

Eikon Therapeutics, Inc is set to IPO on February 5, 2026, on NASDAQ under the ticker EIKN. The shares are expected to be priced between $16.00 and $18.00 each, with a 180-day insider lock-up period ending on August 4, 2026. The company focuses on developing innovative medicines for serious unmet medical needs.

fidelity

Proshares Ultra Nasdaq Biotech

SPDR S&P Biotech

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

VanEck Biotech ETF

iShares Biotechnology ETF

Anika Therap

ESC NEUBASE THERAPEUTI

Invesco Biotechnology & Genome ETF

Preview: Eikon Therapeutics, Inc Set To IPO Tomorrow